Mevastatin
Especificaciones
73573-88-3Número CAS
700-442-0Número CE
[(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoateNombre IUPAC
C23H34O5Fórmula química
390.5 g/molPeso molecular
Mevastatin; compactin; 73573-88-3; Mevastatina; Mevastatine; Mevastatinum; Antibiotic ML 236B; ML-236B lactone; ML-236B; ML236B lactone; ML 236 B; CS 500; CS-500; DTXSID4040684; 1UQM1K0W9X; CS500; NSC-281245; NSC-759322; L-637312; [(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate; DTXCID2020684; CHEBI:34848; L637312; NSC281245; 7-(1,2,6,7,8,8a-Hexahydro-2-methyl-8-(2-methylbutyryloxy)naphthyl)-3-hydroxyheptan-5-olide; (1S,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl(2S)-2-methylbutanoate; ML236B; 6-demethylmevinolin; ((1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxooxan-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) (2S)-2-methylbutanoate; RefChem:53384; EC 700-442-0; 658-033-7; 700-442-0; Mevastatin [INN]; Mevastatinum [INN-Latin]; Compactin;ML236B; (1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (S)-2-methylbutanoate; MFCD05662341; CHEMBL54440; Butanoic acid, 2-methyl-, (1S,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-7-methyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)-; (1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate; M02108; (1S,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-7-methyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthyl (S)-2-methylbutyrate; Compactin (penicillium); Mevastatine [INN-French]; Mevastatina [INN-Spanish]; SMR000336944; (+)-Compactin; CCRIS 4505; Lovastatin EP Impurity A; UNII-1UQM1K0W9X; kompaktin; NCGC00095942-01; Mevastatin/Compactin; Mevastatin (Standard); MEVASTATIN [MI]; MEVASTATIN [JAN]; MEVASTATIN [MART.]; SCHEMBL1116; MEVASTATIN [USP-RS]; Lopac0_000754; MLS000721804; MLS000759452; MLS001424284; MLS002207227; Compactin, 6-Demethylvevinolin, CS-500, ML-236 B; GTPL3031; Mevastatin - Bio-X trade mark; orb1224108; orb1310389; orb3139879; Mevastatin, >=96% (HPLC); HMS2052P07; HMS2089D10; HMS2232N09; HMS3262G10; HMS3268A19; HMS3412H15; HMS3676H15; HMS3713B06; [(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate; MSK10322; Compactin, Mevastatinum, Mevastatina; Tox21_111540; Tox21_500754; BDBM50011036; HY-17408R; NSC779705; s4223; AKOS015994712; Mevastatin, >=95% (HPLC), powder; CCG-101174; CS-1234; DB06693; EBC-615461; FM25991; KS-1085; LP00754; NC00424; NSC 759322; NSC-779705; SDCCGSBI-0050732.P002; SMP1_000077; NCGC00025202-04; NCGC00025202-09; NCGC00261439-01; BM164666; Butanoic acid, 2-methyl-, (1S,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-7-methyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)-; Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-7-methyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1-alpha(R*),7-beta,8-beta(2S*,4S*),8a-beta))-; HY-17408; Mevastatin 100 microg/mL in Acetonitrile; SY077144; CAS-73573-88-3; LOVASTATIN IMPURITY A [EP IMPURITY]; EU-0100754; M2275; H11997; M 2537; AB00588266-06; AB00588266-08; AB00588266_09; Q414407; SR-01000729493; SR-01000729493-4; BRD-K94441233-001-03-1; BRD-K94441233-001-12-2; BRD-K94441233-001-13-0; BRD-K94441233-001-17-1; (1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate; (S)-((1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2-methylbutanoate; (S)-((1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2-methylbutanoate; (S)-2-Methyl-butyric acid (1S,7S,8S,8aR)-8-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester; 2-Methyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester; 2-Methyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester((+)-compactin); 2-Methyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester(compactin); Lovastatin EP Impurity A; Pravastatin Deshydroxy Impurity; Mevastatin; Compactin (Penicillium)Sinónimos
Productos que contienen Mevastatin
Empresas que venden Mevastatin
LG
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.ChinaHD
Hangzhou Dingyan Chem Co., LtdChinaCD
CHONGQING DAXIN PHARMACEUTICAL CO., LTD.ChinaGB
Guangdong Blue Treasure Pharmaceuticals Co. Ltd.China
LN
Livzon New North River PharmaceuticalChina